EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Reversible Covalent Inhibition─Desired Covalent Adduct Formation by Mass Action

Disha Patel, Zil E Huma, Dustin Duncan iD

ACS Chemical Biology · 19.04.2024 · 19 (4) · 824-838

DOI: 10.1021/acschembio.3c00805 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Chemical Biology, online erschienen am 03.04.2024. Verfasst von Disha Patel und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Brock University, St. Catharines, Ontario L2S 3A1, Canada. Hauptthemen laut MEDLINE: Proteins. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Brock University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Covalent inhibition has seen a resurgence in the last several years. Although long-plagued by concerns of off-target effects due to nonspecific reactions leading to covalent adducts, there has been success in developing covalent inhibitors, especially within the field of anticancer therapy. Covalent inhibitors can have an advantage over noncovalent inhibitors since the formation of a covalent adduct may serve as an additional mode of selectivity due to the intrinsic reactivity of the target protein that is absent in many other proteins. Unfortunately, many covalent inhibitors form irreversible adducts with off-target proteins, which can lead to considerable side-effects. By designing the inhibitor to form reversible covalent adducts, one can leverage competing on/off kinetics in complex formation by taking advantage of the law of mass action. Although covalent adducts do form with off-target proteins, the reversible nature of inhibition prevents accumulation of the off-target adduct, thus limiting side-effects. In this perspective, we outline important characteristics of reversible covalent inhibitors, including examples and a guide for inhibitor development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteinsAntineoplastic AgentsHumans

Substanzen

ProteinsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Chemistry, Brock University, St. Catharines, Ontario L2S 3A1, Canada.

ORCID-Profile: Dustin Duncan

Förderung

  • Brock University

Zitieren

APA

Patel, D., Huma, Z. E., & Duncan, D. (2024). Reversible Covalent Inhibition─Desired Covalent Adduct Formation by Mass Action. ACS Chemical Biology, 19(4), 824-838. https://doi.org/10.1021/acschembio.3c00805

Vancouver

Patel D, Huma ZE, Duncan D. Reversible Covalent Inhibition─Desired Covalent Adduct Formation by Mass Action. ACS Chemical Biology. 2024;19(4):824-838. doi:10.1021/acschembio.3c00805

BibTeX
@article{Patel2024,
  author = {Patel, Disha and Huma, Zil E and Duncan, Dustin},
  title = {Reversible Covalent Inhibition─Desired Covalent Adduct Formation by Mass Action},
  journal = {ACS Chemical Biology},
  year = {2024},
  volume = {19},
  number = {4},
  pages = {824--838},
  doi = {10.1021/acschembio.3c00805}
}
Kostenlos starten →